I never expected CD10 to get EUA, and NASDAQ never really seemed like we were getting listed without first getting something approved, so the content of the call was pretty much in line with my expectations.

Hopefully the Executive Comp proposal is DOA now. That would be the only sliver lining I could take from yesterday.

We took our plunge today, so now we sit back and wait for CD12 interim results. That's the one folks. It always was for COVID, and now it is our last shot on this goal. We will NEVER complete a P3 for m/m- simply won't happen- I'd bet my entire holdings against it. If we can't get approval with these interim results, I really don't know if we have a shot at impacting the COVID landscape at all, and certainly not enough to create the wild prices that have been thrown around here.